Mankind pharma ipo grey market premium

Mankind Pharma shares managed to attract single-digit premium in the grey market on the day of price band announcement and ahead of the IPO launch. The expensive valuations and only offer for sale portion in the IPO may be reasons for low premium, experts said. The offer will open for subscription in the coming week on April 25 and the closing date would be April 27, 2023. The pharmaceutical company on April 19 has fixed price band for its IPO at Rs 1,026-1,080 per share. More than 4 crore shares public issue is completely an offer for sale by promoters and investors, which means the company will not get funds through this offer and the entire amount will go to selling shareholders. The public issue in total will fetch the company Rs 4,326.35 crore at higher end of price band. Currently its shares are traded with around 7-8 percent premium in the grey market, analysts said. The grey market is an unofficial trading platform for IPO shares and is generally used by investors to know about expected demand to the issue and listing price. "The current grey market premium of Mankind Pharma of about 7 percent is not encouraging, considering the size of the IPO at about Rs 4,300 crore," Manish Chowdhury, Head of Research at Stoxbox said. He expects the grey market premium to dilute further over the period due to expensive valuations, higher borrowings and no use of proceeds for business purposes. He believes that there are better opportunities in the pharmaceutical space available ...

May 9, 2023 admin [ssba] • • • • Mankind Pharma IPO Particulars & Guidance @ Chanakyanipothi.com, India`s Oldest & the most Trusted Investment website for coming up IPOs. Operational since 8th December 1999, this is the Only Investment website in India, which has successfully completed 23 Years. Mankind IPO listing at which price?The scrip will list on 9th May 2023. The grey market of the IPO witnessed sharp volatility. At one time the GMP had declined to Zero and there were no trades seen and then suddenly the GMP shot up to Rs. 73 and gradually improved to current level of Rs. 100/103. However, the traders show complete uncertainty about listing price. The way the promoters are Expert & energetic about the marketing, promotions and new launches, we expect positive listing, not just Rs. 1200, but there are all chances that on listing day, the scrip moves up to Rs. 1400 and yet there are large number of investors and traders who are skeptical of listing. They fear negative listing. Actual Listing: The scrip listed at Rs. 1300 and during the intraday, it moved up to Rs. 1393.65 Whether you should apply in Mankind Pharma IPO? The management has formed habit of very fast and impressive growth. Highly capable of developing strong brands in Pharma and FMCG businesses. Grown organically and is the youngest company among the five largest pharmaceutical companies in India, in terms of Domestic Sales in the Financial Year 2022. At a first glance, the price may appear to be high, gr...

Mankind Pharma IPO: After closure of subscription, bidders and market observers are eagerly waiting for announcement of share allotment date, which is most likely on 3rd May 2023. As per the tentative schedule of this Prega News and Manforce maker company's initial public offering (IPO), Mankind Pharma IPO allotment date is most likely on 3rd May 2023. However, those who have applied for the IPO need not to move from pillar to post as they can check their application status online by logging in at the BSE website or at official registrar's website. Meanwhile, as Mankind Pharma IPO allotment date is fast approaching, grey market has gone bullish on the public issue as the secondary market has been in uptrend for last six days. According to market observers, shares of Mankind Pharma Ltd are available at a premium of ₹92 in grey market today. Mankind Pharma IPO GMP today Market observers said that Mankind Pharma IPO grey market premium (GMP) today is ₹92, which is ₹7 higher from its yesterday's GMP of ₹85 apiece. They said that Mankind Pharma IPO GMP has risen from ₹60 to ₹92 in last three days, which is mainly due to the trend reversal on Dalal Street. They said that bullish sentiments at Indian stock market has changed grey market sentiments in regard to Mankind Pharma IPO. What this GMP mean? Primary market observers went on to add that ₹92, which means grey market is expecting that Mankind Pharma IPO listing price would be around ₹1172 ( ₹1080 + ₹92), which is 8.50 per ce...

Mankind Pharma IPO (initial public offering) is opening for subscription today and the public issue worth ₹4,326.36 crore will remain open for bidding till 27th April 2023. The pharma company, which has over 36 brands including Manforce and Prega News, has fixed Mankind Pharma IPO price band at ₹1026 to ₹1080 per equity share. Mankind Pharma IPO, which is completely OFS (offer for sale) in nature had made its debut in grey market before hitting the primary market on Dalal Street. According to market observers, shares of Mankind Pharma are available at a premium of ₹90 in grey market today. 1] Mankind Pharma IPO date: The public issue has opened today and it will remain open for bidding till 27th April 2023. 2] Mankind Pharma IPO price band: Manforce and Prega News maker company has fixed price band of its public offer at ₹1026 to ₹1080 apiece. 3] Mankind Pharma IPO GMP: According to market observers, Mankind Pharma IPO GMP today is ₹90, which is ₹15 higher from its Monday GMP of ₹75 per share. 4] Mankind Pharma IPO lot size: A bidder will be able to apply in lots and one lot of the IPO will comprise 13 shares. 5] Mankind Pharma IPO investment limit: As one lot will have 13 company shares, minimum amount required for a retail investor to apply for Mankind Pharma IPO is ₹14,040 ( ₹1080 x 13). 6] Mankind Pharma IPO allotment date: Most likely date for share allocation is 3rd May 2023. 7] Mankind Pharma IPO registrar: Kfin Technologies Limited has been appointed as official re...

The selling shareholders in the OFS of Mankind Pharma would be the promoter group as well as some of the early private equity and other institutional investors as under. Name of Seller in OFS Status of seller in OFS Maximum Shares to be sold Ramesh Juneja Promoter shareholder 37,05,443 shares Rajeev Juneja Promoter shareholder 35,05,149 shares Sheetal Arora Promoter shareholder 28,04,119 shares Cairnhill CIPEF Limited Investor shareholder 174,05,559 shares Cairnhill CGPE Limited Investor shareholder 26,23,863 shares Beige Limited Investor shareholder 99,64,711 shares Link Investment Trust Investor shareholder 50,000 shares The issue of Mankind Pharma opens for subscription on 25th April 2023 and closes for subscription on 27th April 2023 (both days inclusive). The basis of allotment will be finalized on 03rd May 2023 and the refunds will be initiated on 04th May 2023. In addition, the demat credits are expected to happen on 05th May 2023 and the stock is scheduled to list on 08th May 2023 on the NSE and the BSE. Mankind Pharma IPO GMP The grey market price (GMP) trading normally starts about 4-5 days prior to IPO opening and continues till the listing date. In the case of Mankind Pharma Ltd, we already have GMP data for the last 5 days, which should give a reasonable post-listing picture. There are 2 factors that impact the GMP. Firstly, the market conditions have a deep impact on the GMP, which includes the levels of the Nifty and Sensex as well as the general IPO market ...

The selling shareholders in the OFS of Mankind Pharma would be the promoter group as well as some of the early private equity and other institutional investors as under. Name of Seller in OFS Status of seller in OFS Maximum Shares to be sold Ramesh Juneja Promoter shareholder 37,05,443 shares Rajeev Juneja Promoter shareholder 35,05,149 shares Sheetal Arora Promoter shareholder 28,04,119 shares Cairnhill CIPEF Limited Investor shareholder 174,05,559 shares Cairnhill CGPE Limited Investor shareholder 26,23,863 shares Beige Limited Investor shareholder 99,64,711 shares Link Investment Trust Investor shareholder 50,000 shares The issue of Mankind Pharma opens for subscription on 25th April 2023 and closes for subscription on 27th April 2023 (both days inclusive). The basis of allotment will be finalized on 03rd May 2023 and the refunds will be initiated on 04th May 2023. In addition, the demat credits are expected to happen on 05th May 2023 and the stock is scheduled to list on 08th May 2023 on the NSE and the BSE. Mankind Pharma IPO GMP The grey market price (GMP) trading normally starts about 4-5 days prior to IPO opening and continues till the listing date. In the case of Mankind Pharma Ltd, we already have GMP data for the last 5 days, which should give a reasonable post-listing picture. There are 2 factors that impact the GMP. Firstly, the market conditions have a deep impact on the GMP, which includes the levels of the Nifty and Sensex as well as the general IPO market ...

May 9, 2023 admin [ssba] • • • • Mankind Pharma IPO Particulars & Guidance @ Chanakyanipothi.com, India`s Oldest & the most Trusted Investment website for coming up IPOs. Operational since 8th December 1999, this is the Only Investment website in India, which has successfully completed 23 Years. Mankind IPO listing at which price?The scrip will list on 9th May 2023. The grey market of the IPO witnessed sharp volatility. At one time the GMP had declined to Zero and there were no trades seen and then suddenly the GMP shot up to Rs. 73 and gradually improved to current level of Rs. 100/103. However, the traders show complete uncertainty about listing price. The way the promoters are Expert & energetic about the marketing, promotions and new launches, we expect positive listing, not just Rs. 1200, but there are all chances that on listing day, the scrip moves up to Rs. 1400 and yet there are large number of investors and traders who are skeptical of listing. They fear negative listing. Actual Listing: The scrip listed at Rs. 1300 and during the intraday, it moved up to Rs. 1393.65 Whether you should apply in Mankind Pharma IPO? The management has formed habit of very fast and impressive growth. Highly capable of developing strong brands in Pharma and FMCG businesses. Grown organically and is the youngest company among the five largest pharmaceutical companies in India, in terms of Domestic Sales in the Financial Year 2022. At a first glance, the price may appear to be high, gr...

Mankind Pharma IPO (initial public offering) is opening for subscription today and the public issue worth ₹4,326.36 crore will remain open for bidding till 27th April 2023. The pharma company, which has over 36 brands including Manforce and Prega News, has fixed Mankind Pharma IPO price band at ₹1026 to ₹1080 per equity share. Mankind Pharma IPO, which is completely OFS (offer for sale) in nature had made its debut in grey market before hitting the primary market on Dalal Street. According to market observers, shares of Mankind Pharma are available at a premium of ₹90 in grey market today. 1] Mankind Pharma IPO date: The public issue has opened today and it will remain open for bidding till 27th April 2023. 2] Mankind Pharma IPO price band: Manforce and Prega News maker company has fixed price band of its public offer at ₹1026 to ₹1080 apiece. 3] Mankind Pharma IPO GMP: According to market observers, Mankind Pharma IPO GMP today is ₹90, which is ₹15 higher from its Monday GMP of ₹75 per share. 4] Mankind Pharma IPO lot size: A bidder will be able to apply in lots and one lot of the IPO will comprise 13 shares. 5] Mankind Pharma IPO investment limit: As one lot will have 13 company shares, minimum amount required for a retail investor to apply for Mankind Pharma IPO is ₹14,040 ( ₹1080 x 13). 6] Mankind Pharma IPO allotment date: Most likely date for share allocation is 3rd May 2023. 7] Mankind Pharma IPO registrar: Kfin Technologies Limited has been appointed as official re...

Mankind Pharma IPO: After closure of subscription, bidders and market observers are eagerly waiting for announcement of share allotment date, which is most likely on 3rd May 2023. As per the tentative schedule of this Prega News and Manforce maker company's initial public offering (IPO), Mankind Pharma IPO allotment date is most likely on 3rd May 2023. However, those who have applied for the IPO need not to move from pillar to post as they can check their application status online by logging in at the BSE website or at official registrar's website. Meanwhile, as Mankind Pharma IPO allotment date is fast approaching, grey market has gone bullish on the public issue as the secondary market has been in uptrend for last six days. According to market observers, shares of Mankind Pharma Ltd are available at a premium of ₹92 in grey market today. Mankind Pharma IPO GMP today Market observers said that Mankind Pharma IPO grey market premium (GMP) today is ₹92, which is ₹7 higher from its yesterday's GMP of ₹85 apiece. They said that Mankind Pharma IPO GMP has risen from ₹60 to ₹92 in last three days, which is mainly due to the trend reversal on Dalal Street. They said that bullish sentiments at Indian stock market has changed grey market sentiments in regard to Mankind Pharma IPO. What this GMP mean? Primary market observers went on to add that ₹92, which means grey market is expecting that Mankind Pharma IPO listing price would be around ₹1172 ( ₹1080 + ₹92), which is 8.50 per ce...

Mankind Pharma shares managed to attract single-digit premium in the grey market on the day of price band announcement and ahead of the IPO launch. The expensive valuations and only offer for sale portion in the IPO may be reasons for low premium, experts said. The offer will open for subscription in the coming week on April 25 and the closing date would be April 27, 2023. The pharmaceutical company on April 19 has fixed price band for its IPO at Rs 1,026-1,080 per share. More than 4 crore shares public issue is completely an offer for sale by promoters and investors, which means the company will not get funds through this offer and the entire amount will go to selling shareholders. The public issue in total will fetch the company Rs 4,326.35 crore at higher end of price band. Currently its shares are traded with around 7-8 percent premium in the grey market, analysts said. The grey market is an unofficial trading platform for IPO shares and is generally used by investors to know about expected demand to the issue and listing price. "The current grey market premium of Mankind Pharma of about 7 percent is not encouraging, considering the size of the IPO at about Rs 4,300 crore," Manish Chowdhury, Head of Research at Stoxbox said. He expects the grey market premium to dilute further over the period due to expensive valuations, higher borrowings and no use of proceeds for business purposes. He believes that there are better opportunities in the pharmaceutical space available ...